Oregon Public Employees Retirement Fund lowered its holdings in shares of Stryker Corporation (NYSE:SYK) by 4.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 84,835 shares of the medical technology company’s stock after selling 3,574 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Stryker Corporation were worth $12,048,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of SYK. BlackRock Inc. boosted its holdings in Stryker Corporation by 2,526.4% during the 1st quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock valued at $2,893,242,000 after acquiring an additional 21,140,000 shares during the period. Koch Industries Inc. raised its position in Stryker Corporation by 34,120.3% during the 2nd quarter. Koch Industries Inc. now owns 1,260,675 shares of the medical technology company’s stock valued at $1,252,000 after purchasing an additional 1,256,991 shares in the last quarter. Vanguard Group Inc. raised its position in Stryker Corporation by 5.2% during the 1st quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock valued at $3,083,382,000 after purchasing an additional 1,161,688 shares in the last quarter. Janus Henderson Group PLC raised its position in Stryker Corporation by 2,237.8% during the 2nd quarter. Janus Henderson Group PLC now owns 1,019,254 shares of the medical technology company’s stock valued at $141,452,000 after purchasing an additional 975,656 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its position in Stryker Corporation by 41.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,403,420 shares of the medical technology company’s stock valued at $184,759,000 after purchasing an additional 414,715 shares in the last quarter. Institutional investors own 74.13% of the company’s stock.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the sale, the insider now owns 83,207 shares in the company, valued at approximately $12,925,375.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 7.40% of the company’s stock.

Shares of Stryker Corporation (NYSE SYK) traded up $0.29 during trading hours on Wednesday, reaching $156.51. The company had a trading volume of 297,703 shares, compared to its average volume of 1,269,563. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $160.62. The firm has a market cap of $58,250.08, a price-to-earnings ratio of 24.67, a P/E/G ratio of 2.45 and a beta of 0.79. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63.

Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The company had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.97 billion. During the same period in the prior year, the company posted $1.39 EPS. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. equities analysts predict that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Position Cut by Oregon Public Employees Retirement Fund” was posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/08/stryker-corporation-syk-position-cut-by-oregon-public-employees-retirement-fund.html.

SYK has been the subject of a number of research analyst reports. BMO Capital Markets reaffirmed a “hold” rating and set a $140.00 target price on shares of Stryker Corporation in a research report on Tuesday, July 11th. Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price for the company in a research report on Monday, July 17th. Royal Bank Of Canada lifted their target price on Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Oppenheimer Holdings, Inc. set a $148.00 target price on Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Finally, Stifel Nicolaus lifted their target price on Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Stryker Corporation presently has an average rating of “Hold” and an average price target of $151.52.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.